CXCL17 Human Recombinant produced in
E. coli is a single, non-glycosylated polypeptide chain containing 98 amino acids and having a molecular mass of 11.5 kDa. The CXCL17 is purified by proprietary chromatographic techniques.
Synonyms: VEGF coregulated chemokine 1, C-X-C motif chemokine 17, Dendritic cell and monocyte chemokine-like protein, DMC, CXCL17, VCC1, Dcip1, VCC-1, UNQ473.
Formulation: CXCL17 protein was lyophilized from a 0.2 µm filtered concentrated solution in PBS, pH 7.4, containing 3% Trehalose.
Physical Appearance: Sterile Filtered White lyophilized (freeze-dried) powder.
Purity: Greater than 97% as determined by: (a) Analysis by RP-HPLC. (b) Analysis by SDS-PAGE.
Source:Escherichia coli.Amino acid sequence: SSLNPGVARG HRDRGQASRR WLQEGGQECE CKDWFLRAPR RKFMTVSGLP KKQCPCDHFK GNVKKTRHQR HHRKPNKHSR ACQQFLKQCQ LRSFALPL.
Uniprot ACC number: Q6UXB2
Transportation method: Shipped at room temperature.
Stability: Lyophilized CXCL17 although stable at room temperature.erature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution CXCL17 should be stored at 4°C between 2-7 days and for future use below -18°C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA). Please prevent freeze-thaw cycles.
Biological Activity: The ED50 as determined by its ability to induce VEGF expression using murine endothelial cells is less than 5.0µg/ml, corresponding to a specific activity of > 200 IU/mg.
Solubility: It is recommended to reconstitute the lyophilized CXCL17 in sterile 18M-cm H
2O not less than 100 µg/ml, which can then be further diluted to other aqueous solutions.
Safety data sheet: Inquire at info@3hbiomedical.com